Related Articles
BARRETTS CARCINOMA IN A 25-YEAR-OLD MAN WITH POINT MUTATION OF THE P53 TUMOR SUPPRESSOR GENE
Clinicopathological and immunohistochemical study of cancer arising from Barrett's esophagus.
p53 in esophageal adenocarcinoma: A critical reassessment of mutation frequency and identification of 72Arg as the dominant allele
Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus
Expression of vascular cell adhesion molecule-1 (CD 106) in normal and neoplastic human esophageal squamous epithelium